Oral contraceptives and lipids and lipoproteins: Part II-relationship to plasma steroid levels and outlier status
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 40 (6), 675-689
- https://doi.org/10.1016/0010-7824(89)90071-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Oral contraceptives and lipids and lipoproteins: Part I-variations in mean levels by oral contraceptive typeContraception, 1989
- Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.BMJ, 1989
- A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular DiseasesNew England Journal of Medicine, 1988
- Progestins and oral contraceptive-induced lipoprotein changes: A prospective studyContraception, 1986
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisNew England Journal of Medicine, 1986
- Relative potency of progestins used in oral contraceptivesContraception, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindroneContraception, 1980
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971